Insider Cluster (2 insiders) ·Filed Jun 17, 2026

DXCM

DEXCOM INC
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $410K total
Actionable Insight • Neutral

Insider selling at this scale is routine and carries no actionable signal. Monitor future 8-K or 10-Q filings for fundamental changes; this cluster alone does not warrant a trade decision.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
DXCM ▲ +16.85% at T+60d
NEUTRAL call ✓ call won +16.85% · α vs SPY +14.95% · entry $72.47 → $84.68
Entry anchored
Jun 17, 03:59 PM ET
via exchange tick
T+1d
-4.69%
call -4.69% · α -4.38%
$69.07
settled 4mo ago
T+5d
-5.27%
call -5.27% · α -3.61%
$68.65
settled 3mo ago
T+20d
+7.60%
call +7.60% · α +7.07%
$77.98
settled 3mo ago
T+60d
+16.85%
call +16.85% · α +14.95%
$84.68
settled 18d ago

Price Chart

Loading chart...

Executive Summary

Two Dexcom insiders (a director and an EVP) sold a combined $410K in open-market transactions over a one-week window ending June 15, 2026. The total value represents approximately 0.0015% of Dexcom's $28.2B market cap, making these trades trivial in proportion and likely reflecting routine portfolio diversification or tax planning rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$410.0K
Insiders
2

Key Facts

  • Director Mark G. Foletta sold 3,801 shares for $282K on June 15, 2026.
  • EVP & Chief Legal Officer Michael J. Brown sold 1,700 shares for $128K on June 15, 2026.
  • Total insider sales of $410K represent less than 0.002% of Dexcom's $28.2B market capitalization.
  • No insider buying occurred in the same window; both transactions were open-market sales.

Financial Impact

Total insider sales of $410K are negligible relative to $28.2B market cap — no material impact.

Risk Factors

  • Insider sales could accelerate if management becomes more bearish on growth prospects (e.g., CGM market competition or pricing pressure).
  • Low historical win rate on past DXCM calls (0% at T+20) suggests limited predictive signal from routine filings.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (37 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DXCM-1781728389596
11 reports for DXCM
Performance horizon
Filters
Rows
Reports for DXCM — sortable, filterable
TypeNow
Sep 14, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$86.45 $89.53▲ +3.56%▲ +1.44%$85.36 (−1.26%)
Aug 28, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $84.53▼ −7.17%▼ −7.03%$85.36 (−6.26%)
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $91.06· 0.00%▼ −0.47%$85.36 (−6.26%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.76 $91.06▲ +2.59%▲ +3.78%$85.36 (−3.83%)
Jul 21, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.43 $75.14▲ +5.19%▲ +7.60%$85.36 (+19.50%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$72.47 $68.65▼ −5.27%▼ −3.61%$85.36 (+17.79%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$70.17 $73.45▲ +4.67%▲ +3.46%$85.36 (+21.64%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.17 $72.70▲ +3.61%▲ +3.14%$85.36 (+21.64%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.24 $72.27▲ +1.45%▼ −0.36%$85.36 (+19.82%)
Apr 15, 2026
24w ago
DEFA14A
NEUTRAL ★ 2/10
$61.01 $62.68▲ +2.74%▲ +1.75%$85.36 (+39.90%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 17, 2026